Streetbeat News

Regulatory

KXIN

Trading for a certain asset was halted at 7:50:00 p.m. ET due to pending news. This indicates that significant information is expected to be released, which could impact the asset's price once trading resumes.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 11:50 pm

F

TM

The Biden Administration has approved Ioneer's Rhyolite Ridge Lithium-Boron Project in Nevada, marking the first U.S. lithium project approval under the current administration. This move aims to boost domestic battery material sourcing and reduce reliance on China. Ioneer has agreements with Ford and Toyota to supply lithium for electric vehicle batteries.

Portfolio Pulse from Adam Eckert

October 24, 2024 | 10:23 pm

CPRI

TPR

Capri Holdings and Tapestry plan to appeal a district court's decision to grant the FTC's motion for a preliminary injunction blocking their merger.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 10:06 pm

CPRI

TPR

Capri Holdings' stock plummeted after a judge blocked its merger with Tapestry, citing competition concerns in the U.S. handbag market. Tapestry's stock rose as the merger was halted.

Portfolio Pulse from Adam Eckert

October 24, 2024 | 9:39 pm

XRAY

Dentsply Sirona has suspended sales and marketing of its Byte aligners and impression kits to review regulatory requirements in consultation with the FDA.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 9:36 pm

FRST

Primis Financial has received a notice from Nasdaq indicating that the temporary stay of delisting of its common stock has been extended. This development provides the company with more time to comply with Nasdaq's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 9:17 pm

EWJ

Bank of Japan Governor Kazuo Ueda indicated that there will be no interest rate hike next week, suggesting a stable policy stance despite the yen's recent decline. This decision implies that the central bank is not in a rush to adjust its monetary policy.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 8:58 pm

CTHR

Charles & Colvard has received a letter from the Nasdaq Listing Qualifications Department regarding non-compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 8:46 pm

RIGL

Rigel Pharmaceuticals has issued a Dear Healthcare Provider letter for GAVRETO after consulting with the FDA about a new safety signal. GAVRETO is used for treating certain types of cancer, including RET fusion-positive non-small cell lung cancer and thyroid cancer.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 8:42 pm

MDT

Medtronic has received FDA approval for its Affera Mapping and Ablation System, which includes the Sphere-9 catheter. This is the first all-in-one high-definition mapping and dual energy ablation device designed for treating atrial fibrillation and atrial flutter.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 8:36 pm